{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T08:27:47Z","timestamp":1791275267535,"version":"4.1.0"},"reference-count":50,"publisher":"American Society of Hematology","issue":"13","content-domain":{"domain":["ashpublications.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2008,12,15]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>We demonstrate that the secretome of mesenchymal stromal cells (MSCs) suppresses plasma cell (PC) immunoglobulin (Ig) production, induces plasmablast proliferation, and leads to interleukin-10\u2013mediated blockade in vitro. We found that these effects are the result of MSC-derived CC chemokine ligands CCL2 and CCL7. More specifically, MSCs further processed these CC chemokines by the activity of matrix metalloproteinases (MMPs), leading to the generation of proteolytically processed antagonistic CCL2 variant. Neutralizing CCL2 or inhibiting MMP enzymatic activity abolished the PC-suppressive effect of MSCs. We also observed that MMP-processed CCL2 suppresses signal transducer and activator of transcription 3 (STAT3) activation in PC. As a result, the transcription factor PAX5 is induced, thus explaining the inhibition of Ig synthesis. The absence of inhibitory effects by MSC on the humoral response of CCR2\u2212\/\u2212 mice to xenoantigen suggests that MMP-cleaved CCL2\/CCR2 interaction as well as downstream phosphatase activity is necessary for antagonistic effect. We tested syngeneic MSCs in hemophilic B6 mice with predeveloped antihuman factor VIII (hFVIII) antibodies and demonstrated a robust decrease in hFVIII-specific IgG levels. Thus, MSCs may play a role in modulating Ig production by PCs via MMP processing of CCL2 and may represent an appealing cell therapy approach for pathologic humoral responses.<\/jats:p>","DOI":"10.1182\/blood-2008-07-166892","type":"journal-article","created":{"date-parts":[[2008,9,24]],"date-time":"2008-09-24T01:06:36Z","timestamp":1222218396000},"page":"4991-4998","update-policy":"https:\/\/doi.org\/10.1182\/blood.2019cm0000","source":"Crossref","is-referenced-by-count":199,"title":["Mesenchymal stromal cell\u2013derived CCL2 suppresses plasma cell immunoglobulin production via STAT3 inactivation and PAX5 induction"],"prefix":"10.1182","volume":"112","author":[{"given":"Moutih","family":"Rafei","sequence":"first","affiliation":[{"name":"Montreal Centre for Experimental Therapeutics in Cancer and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeremy","family":"Hsieh","sequence":"additional","affiliation":[{"name":"Montreal Centre for Experimental Therapeutics in Cancer and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Simon","family":"Fortier","sequence":"additional","affiliation":[{"name":"Laboratoire d'Oncologie Mol\u00e9culaire, D\u00e9partement de Chimie, Centre BIOMED, Universit\u00e9 du Qu\u00e9bec \u00e0 Montr\u00e9al, Montreal, QC;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"MengYang","family":"Li","sequence":"additional","affiliation":[{"name":"Montreal Centre for Experimental Therapeutics in Cancer and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shala","family":"Yuan","sequence":"additional","affiliation":[{"name":"Montreal Centre for Experimental Therapeutics in Cancer and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elena","family":"Birman","sequence":"additional","affiliation":[{"name":"Montreal Centre for Experimental Therapeutics in Cancer and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kathy","family":"Forner","sequence":"additional","affiliation":[{"name":"Montreal Centre for Experimental Therapeutics in Cancer and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marie-Noelle","family":"Boivin","sequence":"additional","affiliation":[{"name":"Montreal Centre for Experimental Therapeutics in Cancer and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karen","family":"Doody","sequence":"additional","affiliation":[{"name":"McGill Cancer Centre and Department of Biochemistry, McGill University, Montreal, QC; and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michel","family":"Tremblay","sequence":"additional","affiliation":[{"name":"McGill Cancer Centre and Department of Biochemistry, McGill University, Montreal, QC; and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Borhane","family":"Annabi","sequence":"additional","affiliation":[{"name":"Laboratoire d'Oncologie Mol\u00e9culaire, D\u00e9partement de Chimie, Centre BIOMED, Universit\u00e9 du Qu\u00e9bec \u00e0 Montr\u00e9al, Montreal, QC;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jacques","family":"Galipeau","sequence":"additional","affiliation":[{"name":"Montreal Centre for Experimental Therapeutics in Cancer and"},{"name":"Division of Hematology\/Oncology, Jewish General Hospital, McGill University, Montreal, QC"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"234","reference":[{"key":"2019111714501008600_B1","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1097\/00007890-197404000-00001","article-title":"Stromal cells responsible for transferring the microenvironment of the hemopoietic tissues: cloning in vitro and retransplantation in vivo.","volume":"17","author":"Friedenstein","year":"1974","journal-title":"Transplantation"},{"key":"2019111714501008600_B2","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1016\/j.exphem.2005.01.012","article-title":"Cytokine production and hematopoiesis supporting activity of cord blood-derived unrestricted somatic stem cells.","volume":"33","author":"K\u00f6gler","year":"2005","journal-title":"Exp Hematol"},{"key":"2019111714501008600_B3","doi-asserted-by":"crossref","first-page":"1815","DOI":"10.1182\/blood-2004-04-1559","article-title":"Human mesenchymal stem cells modulate allogeneic immune cell responses.","volume":"105","author":"Aggarwal","year":"2005","journal-title":"Blood"},{"key":"2019111714501008600_B4","doi-asserted-by":"crossref","first-page":"2570","DOI":"10.1182\/blood-2005-07-2793","article-title":"Interferon-gamma-stimulated marrow stromal cells: a new type of nonhematopoietic antigen-presenting cell.","volume":"107","author":"Stagg","year":"2006","journal-title":"Blood"},{"key":"2019111714501008600_B5","doi-asserted-by":"crossref","first-page":"3499","DOI":"10.1182\/blood-2007-02-069716","article-title":"Immunomodulatory properties of mesenchymal stromal cells.","volume":"110","author":"Nauta","year":"2007","journal-title":"Blood"},{"key":"2019111714501008600_B6","doi-asserted-by":"crossref","first-page":"4619","DOI":"10.1182\/blood-2003-11-3909","article-title":"Human bone marrow stromal cells inhibit allogeneic T-cell responses by indoleamine 2,3-dioxygenase-mediated tryptophan degradation.","volume":"103","author":"Meisel","year":"2004","journal-title":"Blood"},{"key":"2019111714501008600_B7","doi-asserted-by":"crossref","first-page":"1579","DOI":"10.1016\/S0140-6736(08)60690-X","article-title":"Mesenchymal stem cells for treatment of steroid-resistant, severe, acute graft-versus-host disease: a phase II study.","volume":"371","author":"Le Blanc","year":"2008","journal-title":"Lancet"},{"key":"2019111714501008600_B8","doi-asserted-by":"crossref","first-page":"1755","DOI":"10.1182\/blood-2005-04-1496","article-title":"Mesenchymal stem cells ameliorate experimental autoimmune encephalomyelitis inducing T-cell anergy.","volume":"106","author":"Zappia","year":"2005","journal-title":"Blood"},{"key":"2019111714501008600_B9","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1182\/blood-2005-07-2657","article-title":"Human mesenchymal stem cells modulate B-cell functions.","volume":"107","author":"Corcione","year":"2006","journal-title":"Blood"},{"key":"2019111714501008600_B10","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/j.stem.2007.11.014","article-title":"Mesenchymal stem cell-mediated immunosuppression occurs via concerted action of chemokines and nitric oxide.","volume":"2","author":"Ren","year":"2008","journal-title":"Cell Stem Cell"},{"key":"2019111714501008600_B11","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1634\/stemcells.2005-0333","article-title":"Role and function of matrix metalloproteinases in the differentiation and biologic characterization of mesenchymal stem cells","volume":"24","author":"Mannello","year":"2006","journal-title":"Stem Cells"},{"key":"2019111714501008600_B12","doi-asserted-by":"crossref","first-page":"4055","DOI":"10.1182\/blood-2006-10-051060","article-title":"MMP-2, MT1-MMP, and TIMP-2 are essential for the invasive capacity of human mesenchymal stem cells: differential regulation by inflammatory cytokines.","volume":"109","author":"Ries","year":"2007","journal-title":"Blood"},{"key":"2019111714501008600_B13","doi-asserted-by":"crossref","first-page":"1160","DOI":"10.1182\/blood.V100.4.1160.h81602001160_1160_1167","article-title":"Matrix metalloproteinase processing of monocyte chemoattractant proteins generates CC chemokine receptor antagonists with anti-inflammatory properties in vivo.","volume":"100","author":"McQuibban","year":"2002","journal-title":"Blood"},{"key":"2019111714501008600_B14","doi-asserted-by":"crossref","first-page":"4057","DOI":"10.1182\/blood-2005-03-1004","article-title":"Allogeneic marrow stromal cells are immune rejected by MHC class I- and class II-mismatched recipient mice.","volume":"106","author":"Eliopoulos","year":"2005","journal-title":"Blood"},{"key":"2019111714501008600_B15","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1038\/nprot.2006.4","article-title":"Tricine-SDS-PAGE.","volume":"1","author":"Sch\u00e4gger","year":"2006","journal-title":"Nat Protoc"},{"key":"2019111714501008600_B16","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1182\/blood-2006-02-002246","article-title":"Nitric oxide plays a critical role in suppression of T-cell proliferation by mesenchymal stem cells.","volume":"109","author":"Sato","year":"2007","journal-title":"Blood"},{"key":"2019111714501008600_B17","doi-asserted-by":"crossref","first-page":"1202","DOI":"10.1126\/science.289.5482.1202","article-title":"Inflammation dampened by gelatinase A cleavage of monocyte chemoattractant protein-3.","volume":"289","author":"McQuibban","year":"2000","journal-title":"Science"},{"key":"2019111714501008600_B18","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1002\/(SICI)1521-4141(199802)28:02<508::AID-IMMU508>3.0.CO;2-I","article-title":"IL-10 interrupts memory B cell expansion in the germinal center by inducing differentiation into plasma cells.","volume":"28","author":"Choe","year":"1998","journal-title":"Eur J Immunol"},{"key":"2019111714501008600_B19","doi-asserted-by":"crossref","first-page":"3664","DOI":"10.1002\/eji.200425294","article-title":"CC chemokine receptor 2 regulates leukocyte recruitment and IL-10 production during acute polymicrobial sepsis.","volume":"34","author":"Feterowski","year":"2004","journal-title":"Eur J Immunol"},{"key":"2019111714501008600_B20","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1182\/blood.V91.1.173","article-title":"Generation of plasma cells from peripheral blood memory B cells: synergistic effect of interleukin-10 and CD27\/CD70 interaction.","volume":"91","author":"Agematsu","year":"1998","journal-title":"Blood"},{"key":"2019111714501008600_B21","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1086\/315275","article-title":"Interleukin 10 inhibits the release of CC chemokines during human endotoxemia.","volume":"181","author":"Olszyna","year":"2000","journal-title":"J Infect Dis"},{"key":"2019111714501008600_B22","doi-asserted-by":"crossref","first-page":"9439","DOI":"10.1074\/jbc.M504977200","article-title":"The catalytic activity of the eukaryotic initiation factor-2alpha kinase PKR is required to negatively regulate Stat1 and Stat3 via activation of the T-cell protein-tyrosine phosphatase.","volume":"281","author":"Wang","year":"2006","journal-title":"J Biol Chem"},{"key":"2019111714501008600_B23","doi-asserted-by":"crossref","first-page":"1085","DOI":"10.1182\/blood-2005-07-2871","article-title":"Critical role for Stat3 in T-dependent terminal differentiation of IgG B cells.","volume":"107","author":"Fornek","year":"2006","journal-title":"Blood"},{"key":"2019111714501008600_B24","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1038\/sj.icb.7100134","article-title":"The regulation of the B-cell gene expression programme by Pax5.","volume":"86","author":"Holmes","year":"2008","journal-title":"Immunol Cell Biol"},{"key":"2019111714501008600_B25","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1016\/j.coi.2007.01.003","article-title":"Terminal differentiation of lymphocytes depends on Blimp-1.","volume":"19","author":"Kallies","year":"2007","journal-title":"Curr Opin Immunol"},{"key":"2019111714501008600_B26","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1111\/j.0105-2896.2006.00377.x","article-title":"Transcription factors that regulate memory in humoral responses.","volume":"211","author":"Calame","year":"2006","journal-title":"Immunol Rev"},{"key":"2019111714501008600_B27","doi-asserted-by":"crossref","first-page":"967","DOI":"10.1084\/jem.20040973","article-title":"Plasma cell ontogeny defined by quantitative changes in blimp-1 expression.","volume":"200","author":"Kallies","year":"2004","journal-title":"J. Exp Med"},{"key":"2019111714501008600_B28","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1182\/blood-2003-07-2456","article-title":"Preventing restimulation of memory B cells in hemophilia A: a potential new strategy for the treatment of antibody-dependent immune disorders.","volume":"104","author":"Hausl","year":"2004","journal-title":"Blood"},{"key":"2019111714501008600_B29","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1146\/annurev.immunol.22.012703.104807","article-title":"Transcriptional control of early B cell development.","volume":"22","author":"Busslinger","year":"2004","journal-title":"Annu Rev Immunol"},{"key":"2019111714501008600_B30","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1146\/annurev.immunol.19.1.595","article-title":"B cell development pathways.","volume":"19","author":"Hardy","year":"2001","journal-title":"Annu Rev Immunol"},{"key":"2019111714501008600_B31","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1016\/S1074-7613(01)00153-4","article-title":"Pax5\/BSAP maintains the identity of B cells in late B lymphopoiesis.","volume":"14","author":"Horcher","year":"2001","journal-title":"Immunity"},{"key":"2019111714501008600_B32","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1016\/S1074-7613(01)00153-4","article-title":"Pax5\/BSAP maintains the identity of B cells in late B lymphopoiesis.","volume":"14","author":"Horcher","year":"2001","journal-title":"Immunity"},{"key":"2019111714501008600_B33","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1084\/jem.183.2.393","article-title":"Transcription factor B cell lineage-specific activator protein regulates the gene for human X-box binding protein 1.","volume":"183","author":"Reimold","year":"1996","journal-title":"J Exp Med"},{"key":"2019111714501008600_B34","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1016\/S1074-7613(00)80263-0","article-title":"An interleukin-2 signal relieves BSAP (Pax5)-mediated repression of the immunoglobulin J chain gene.","volume":"5","author":"Rinkenberger","year":"1996","journal-title":"Immunity"},{"key":"2019111714501008600_B35","doi-asserted-by":"crossref","first-page":"3611","DOI":"10.1128\/MCB.13.6.3611","article-title":"NF-HB (BSAP) is a repressor of the murine immunoglobulin heavy-chain 3\u2032\u03b1 enhancer at early stages of B-cell differentiation.","volume":"13","author":"Singh","year":"1993","journal-title":"Mol Cell Biol"},{"key":"2019111714501008600_B36","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/S1074-7613(00)80420-3","article-title":"In vivo occupancy of the \u00ea light chain enhancers in primary pro- and pre-B cells: a model for \u03ba locus activation.","volume":"6","author":"Shaffer","year":"1997","journal-title":"Immunity"},{"key":"2019111714501008600_B37","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1016\/j.immuni.2006.01.012","article-title":"Gene repression by Pax5 in B cells is essential for blood cell homeostasis and is reversed in plasma cells.","volume":"24","author":"Delogu","year":"2006","journal-title":"Immunity"},{"key":"2019111714501008600_B38","doi-asserted-by":"crossref","first-page":"1614","DOI":"10.1182\/blood-2004-07-2507","article-title":"Generation of migratory antigen-specific plasma blasts and mobilization of resident plasma cells in a secondary immune response.","volume":"105","author":"Odendahl","year":"2005","journal-title":"Blood"},{"key":"2019111714501008600_B39","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1016\/j.immuni.2004.05.001","article-title":"Cellular niches controlling B lymphocyte behavior within bone marrow during development.","volume":"20","author":"Tokoyoda","year":"2004","journal-title":"Immunity"},{"key":"2019111714501008600_B40","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1038\/nri1886","article-title":"Competence and competition: the challenge of becoming a long-lived plasma cell.","volume":"6","author":"Radbruch","year":"2006","journal-title":"Nat Rev Immunol"},{"key":"2019111714501008600_B41","doi-asserted-by":"crossref","first-page":"4034","DOI":"10.4049\/jimmunol.160.8.4034","article-title":"Posttranslational modifications affect the activity of the human monocyte chemotactic proteins MCP-1 and MCP-2: identification of MCP-2(6-76) as a natural chemokine inhibitor.","volume":"160","author":"Proost","year":"1998","journal-title":"J Immunol"},{"key":"2019111714501008600_B42","doi-asserted-by":"crossref","first-page":"4213","DOI":"10.4049\/jimmunol.169.8.4213","article-title":"The role of bone marrow-derived stromal cells in the maintenance of plasma cell longevity.","volume":"169","author":"Minges Wols","year":"2002","journal-title":"J Immunol"},{"key":"2019111714501008600_B43","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1016\/S1074-7613(03)00267-X","article-title":"Blimp-1 is required for the formation of immunoglobulin secreting plasma cells and pre-plasma memory B cells.","volume":"19","author":"Shapiro-Shelef","year":"2003","journal-title":"Immunity"},{"key":"2019111714501008600_B44","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1056\/NEJMoa022328","article-title":"Antimyelin antibodies as a predictor of clinically definite multiple sclerosis after a first demyelinating event.","volume":"349","author":"Berger","year":"2003","journal-title":"N Engl J Med"},{"key":"2019111714501008600_B45","doi-asserted-by":"crossref","first-page":"3840","DOI":"10.4049\/jimmunol.162.7.3840","article-title":"Chemokine receptor responses on T cells are achieved through regulation of both receptor expression and signaling.","volume":"162","author":"Rabin","year":"1999","journal-title":"J Immunol"},{"key":"2019111714501008600_B46","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1038\/7720","article-title":"Independent regulation of the two Pax5 alleles during B-cell development","volume":"21","author":"Nutt","year":"1999","journal-title":"Nat Genet"},{"key":"2019111714501008600_B47","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1016\/j.immuni.2006.02.003","article-title":"Loss of Pax5 promotes plasma cell differentiation.","volume":"24","author":"Nera","year":"2006","journal-title":"Immunity"},{"key":"2019111714501008600_B48","doi-asserted-by":"crossref","first-page":"2363","DOI":"10.1634\/stemcells.2006-0686","article-title":"Angiogenic effects of human multipotent stromal cell conditioned medium activate the PI3K-Akt pathway in hypoxic endothelial cells to inhibit apoptosis, increase survival, and stimulate angiogenesis.","volume":"25","author":"Hung","year":"2007","journal-title":"Stem Cells"},{"key":"2019111714501008600_B49","doi-asserted-by":"crossref","first-page":"1579","DOI":"10.1016\/S0140-6736(08)60690-X","article-title":"Mesenchymal stem cells for treatment of steroid-resistant, severe, acute graft-versus-host disease: a phase II study.","volume":"371","author":"Le Blanc","year":"2008","journal-title":"Lancet"},{"key":"2019111714501008600_B50","doi-asserted-by":"crossref","first-page":"3322","DOI":"10.1182\/blood-2005-05-1860","article-title":"CCR2 is required for CD8-induced graft-versus-host disease.","volume":"9","author":"Terwey","year":"2005","journal-title":"Blood"}],"container-title":["Blood"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/ashpublications.org\/blood\/article-pdf\/112\/13\/4991\/1285323\/zh802508004991.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/ashpublications.org\/blood\/article-pdf\/112\/13\/4991\/1285323\/zh802508004991.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,20]],"date-time":"2023-05-20T01:59:21Z","timestamp":1684547961000},"score":1,"resource":{"primary":{"URL":"https:\/\/ashpublications.org\/blood\/article\/112\/13\/4991\/24886\/Mesenchymal-stromal-cellderived-CCL2-suppresses"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,12,15]]},"references-count":50,"journal-issue":{"issue":"13","published-print":{"date-parts":[[2008,12,15]]}},"URL":"https:\/\/doi.org\/10.1182\/blood-2008-07-166892","relation":{},"ISSN":["0006-4971","1528-0020"],"issn-type":[{"value":"0006-4971","type":"print"},{"value":"1528-0020","type":"electronic"}],"subject":[],"published":{"date-parts":[[2008,12,15]]}}}